Polymorphisms in a number of candidate genes have been reported to be associated with obesity. We have determined the incidence of the following polymorphisms in the following candidate genes in a group of 388 morbid obese patients (mean body mass index (BMI) 52 AE 8.01) who underwent gastric banding surgery: lipoprotein lipase (LpL) t-93 g and N291S; peroxisome proliferator receptor g (PPARg), P12A, P115Q and c1431t; peroxisome proliferator receptor a (PPARa) L162V; badrenergic receptor 2 (b-AR 2), Q27E; b-adrenergic receptor 3 (b-AR 3) W64R; uncoupling protein 1 (ucp-1), a-3826g, ucp-2, 45 bp insertion. Only for the ucp2 polymorphism did we find a statistically significant association with obesity. The b-AR 3 W64R and ucp-1 a-3826g polymorphisms influenced the rate of the development of obesity and may act synergistically.
Introduction
The risk of becoming obese has a strong genetic component. 1 Since single gene defects resulting in obesity are very rare, it is likely that a combination of polymorphisms in one or more candidate genes may contribute to its development. Association studies between polymorphisms in candidate genes and obesity frequently show conflicting results. This may be due in part to differences in the type of obesity in the populations studied and the presence of confounding factors such as type 2 diabetes (DM2) and hypertriglyceridemia (HTG). Also, the affect of a polymorphism in one candidate gene may be modified by a polymorphism in another. 2 We have determined the frequencies of polymorphisms in the following candidate genes which may be associated with obesity, in a group of subjects which includes morbid obese, DM2 and HTG patients: lipoprotein lipase (LpL), which produces free fatty acids which can be taken up by adipocytes, N291S; peroxisome proliferator activated receptor (PPAR) g, P12A and c1431t and PPARa, L162V. PPARs are transcription factors which regulate lipid metabolism and adipocyte differentiation; b-adrenergic receptor (b-AR)-2, Q27E and b-AR 3, W64R. These receptors are involved in lipolysis in fat cells; uncoupling protein (ucp)-1, a-3826g and ucp-2, 45 bp insertion. These proteins are involved in thermogenesis.
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Material and methods
Subjects
Three patient groups were included in this study. These were: (1) 381 patients from the Medical Clinic, Universitäts-Krankenhaus, Eppendorf, Hamburg (UKE). These patients form a heterogeneous group which includes patients attending the lipid and diabetes outpatient clinics and inpatients; (2) 369 morbid obese patients undergoing gastric banding surgery at the Evangelisches Krankenhaus, Dinslaken; (3) 199 blood donors from the Blood Transfusion Service of the UKE.
Patients gave informed consent to the study which was approved by the local ethics committee. The clinical details of the subjects are given in Table 1 . DNA was extracted from the buffy coat obtained from 10 ml EDTA blood using standard methods and the polymorphism frequencies determined following published procedures.
Results
Patient data was combined and re-divided into obese (body mass index (BMI) > 30) and lean (BMI < 30). The minor allele frequencies for each of the polymorphisms are presented in Table 2 . Only the ins allele of ucp-2 was significantly associated with obesity, P ¼ 0.006. This remains significant when patients with DM2 are excluded, P ¼ 0.007. Carriers of the ins allele also had a higher mean BMI, 38 vs 35 kg=m 2 , P ¼ 0.005. The frequency of the g allele of the ucp-1 polymorphism in obese subjects who were ins=ins homozygous for the ucp-2 polymorphism, f ¼ 0.35, was higher than in non-obese ins=ins subjects, f ¼ 0.19, P ¼ 0.057. In no case was the difference in allele frequencies between patients with and without DM2 statistically significant. The frequency of the g allele of the ucp-1 polymorphism was significantly higher in younger obese subjects, P ¼ 0.009. The mean age obese patients who were g carriers was significantly lower than aa homozygotes, 36 vs 40 y, P ¼ 0.007. This difference was magnified amongst patients who were carriers of the R allele of the bA-3 polymorphism, 33 vs 45 y, P ¼ 0.006. As many subjects had HTG, we also compared allele frequencies in HTG subjects (TG > 150 mg=dl) with those with normal levels. The R allele frequency of the bA-3 polymorphism was significantly higher in HTG subjects, P ¼ 0.02 and the A allele frequency of the PPARg polymorphism significantly lower, P ¼ 0.03. No significant effects were seen when the subjects were further divided according to BMI.
Discussion
The frequencies of eight polymorphisms in seven candidate genes for obesity in obese and non-obese subjects were compared. Only for the ucp-2, 45 bp insertion polymorphism was there a significant association with obesity suggesting a role for variation in this gene in obesity. Obese subjects who were carriers of the G allele were significantly younger which is consistent with the finding that carriers of the G allele show an increased tendency to gain weight. 11 That the ucp-1 and b3-AR polymorphisms act synergistically to accelerate the development of obesity, and that there is an increase in the frequency of g carriers of the ucp-1 polymorphism in obese subjects who are homozygous for the ucp-2 polymorphism, suggests that a combination of polymorphisms may be a factor in the development of obesity. To confirm this hypothesis will require the recruitment of many more subjects. Polymorphisms and obesity D Evans et al
